Call Now To Order: 1 (833) 587-4268
CBD Set To Conquer World

CBD Set To Conquer World


CBD’s popularity has scientists excited.

Everyone from high-end hotels to health researchers has jumped aboard the CBD bandwagon. And there are plenty of good reasons for that.

A recent article in the New York Times goes into great detail about the appeal of CBD to broad swaths of the United States. That appeal has some doubting the efficacy of the cannabis extract. But the newspaper points out that scientists are equally excited:

Skeptics who assume CBD is just 21st-century snake oil, however, may be surprised to learn that the substance is being studied as a potential treatment for maladies as diverse as schizophrenia, insomnia and cancer.

“CBD is the most promising drug that has come out for neuropsychiatric diseases in the last 50 years,” said Dr. Esther Blessing, an assistant professor at New York University School of Medicine, who is coordinating a study of CBD as a treatment for post-traumatic stress disorder and alcohol use disorder. “The reason it is so promising is that it has a unique combination of safety and effectiveness across of very broad range of conditions.”

The National Institutes of Health database lists about 150 of studies involving CBD as a treatment for conditions as varied as infantile spasms and Parkinson’s disease.

The Wall Street Journal also has a recent article chronicling the growing popularity of the non-psychoactive substance most commonly derived from industrial hemp.

According to the Journal:

Thanks to CBD’s popularity, consumers are realizing that not all cannabinoids—the active chemical compounds in marijuana and hemp—get you stoned. Research suggests that some cannabinoids may, in fact, increase focus, suppress appetite and keep users awake. The steady wave of legalization has been thrilling for cannabinoid scientists, who say these compounds could help treat a variety of ailments, including autism and cancer. As two National Institutes of Health researchers wrote in a 2013 study published in the Federation of European Biochemical Societies journal, cannabinoids “may have therapeutic potential in almost all diseases affecting humans.”

Submit a Comment

Your email address will not be published.